CCL2 and central nervous system cancer: It is noteworthy that in murine glioma models, various vaccines strategies using CCL2[33], CpG[34], IL12-expressing stroma cells[35] or IL23-expressing dendritic cells[36], induced an increased recruitment of NK cells at the tumor site, associated with better overall survival.